Activation-optimized anti-CD3 valency control enables combinatorial discovery of multi-specific nanoantibodies for solid tumor immunotherapy - Long Zhu; Ya-Jing Ma; Jian-Kang Kang; Xiu-Hai Che; Dong-Kun Zhao; Yin-Yi Cai; Yao-Ru Yu; Song Shen; Jun Wang (Science Bulletin, 2026)